関連する実験動画

Updated: Sep 9, 2025

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

11.3K

機能的および構造的コネクトミクスを活用して,の神経調節を導く

Ketan Mehta1, Arianna Damiani2, Elvira Pirondini2

  • 1Department of Biomedical Engineering, Duke University, Durham, North Carolina, U.S.A.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
|September 3, 2025
PubMed
まとめ

構造的な問題だけでなく 脳のネットワークの障害も含まれます 精密神経調節は 患者特有の発作ネットワークをターゲットに 合わせた治療のために 接続データを使用します

キーワード:
エピレプトゲンネットワーク機能的なコネクトームネットワーク障害患者特有のパーソナライズされた神経調節構造コネクトーム

さらに関連する動画

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

12.5K
Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

880

関連する概念動画

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
445